In line with these ex vivo data, in vitro experiments showed that AnxA1-mediated signals effectively down-modulated galectin-3 expression in macrophages isolated from NASH livers (Fig. 7). The gene discussed is ANXA1; the disease is metabolic dysfunction-associated steatohepatitis.